IQ-AI (IQAI) Competitors GBX 0.80 0.00 (0.00%) As of 05/27/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock IQAI vs. FDBK, TRLS, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, and COGShould you be buying IQ-AI stock or one of its competitors? The main competitors of IQ-AI include Feedback (FDBK), Trellus Health (TRLS), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), and Cambridge Cognition (COG). These companies are all part of the "health information services" industry. IQ-AI vs. Its Competitors Feedback Trellus Health DeepVerge Sensyne Health EMIS Group Craneware Instem Kooth Renalytix Cambridge Cognition Feedback (LON:FDBK) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation, community ranking and institutional ownership. Which has stronger earnings & valuation, FDBK or IQAI? IQ-AI has lower revenue, but higher earnings than Feedback. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFeedback£3.88M1.69-£10.84M-£24.74-0.61IQ-AI£538.19K3.30N/AN/AN/A Does the media favor FDBK or IQAI? In the previous week, Feedback's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score. Company Overall Sentiment Feedback Neutral IQ-AI Neutral Which has more risk & volatility, FDBK or IQAI? Feedback has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Comparatively, IQ-AI has a beta of 2.25, suggesting that its stock price is 125% more volatile than the S&P 500. Do insiders & institutionals hold more shares of FDBK or IQAI? 53.2% of Feedback shares are held by institutional investors. 10.8% of Feedback shares are held by insiders. Comparatively, 66.0% of IQ-AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community believe in FDBK or IQAI? Feedback received 159 more outperform votes than IQ-AI when rated by MarketBeat users. Likewise, 67.07% of users gave Feedback an outperform vote while only 66.67% of users gave IQ-AI an outperform vote. CompanyUnderperformOutperformFeedbackOutperform Votes16567.07% Underperform Votes8132.93% IQ-AIOutperform Votes666.67% Underperform Votes333.33% Is FDBK or IQAI more profitable? IQ-AI has a net margin of -77.52% compared to Feedback's net margin of -279.16%. Feedback's return on equity of -39.71% beat IQ-AI's return on equity.Company Net Margins Return on Equity Return on Assets Feedback-279.16% -39.71% -22.99% IQ-AI -77.52%-140.75%-22.03% SummaryFeedback beats IQ-AI on 6 of the 11 factors compared between the two stocks. Get IQ-AI News Delivered to You Automatically Sign up to receive the latest news and ratings for IQAI and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IQAI vs. The Competition Export to ExcelMetricIQ-AIHealth Information Services IndustryMedical SectorLON ExchangeMarket Cap£1.77M£210.66M£5.57B£2.91BDividend Yield17.30%6.68%5.27%4.90%P/E Ratio-13.67310.3526.75124.60Price / Sales3.30235.17403.98248,064.88Price / Cash10.2547.1438.2528.07Price / BookN/A5.366.964.64Net IncomeN/A-£15.55M£3.23B£5.91B7 Day PerformanceN/A-1.16%-1.22%6.61%1 Month Performance-3.96%-2.23%6.34%13.53%1 Year PerformanceN/A3.64%33.05%78.98% IQ-AI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IQAIIQ-AIN/AGBX 0.80flatN/AN/A£1.77M£538.19K-13.676Gap UpFDBKFeedbackN/AGBX 14.65-0.7%N/A-80.0%£6.42M£3.88M-0.5924TRLSTrellus HealthN/AGBX 0.90-5.2%N/A-56.9%£1.74M£65.83K-0.2631Gap DownDVRGDeepVergeN/AN/AN/AN/A£1.14M£12.41M-15.0073SENSSensyne HealthN/AN/AN/AN/A£583K£7.81M-0.0270Gap DownEMISEMIS GroupN/AN/AN/AN/A£1.23B£176.86M4,085.111,560CRWCraneware2.4113 of 5 starsGBX 2,060-0.5%GBX 2,800+35.9%-15.7%£885.11M£230.77M76.11734INSInstemN/AN/AN/AN/A£199.62M£61.63M5,928.57500News CoverageKOOKooth2.8737 of 5 starsGBX 181.15+0.4%GBX 456.67+152.1%-44.8%£66.49M£50.72M17.02478RENXRenalytixN/AGBX 7.25flatN/A-63.3%£30.05M£9.22M-0.34102COGCambridge CognitionN/AGBX 39+4.0%N/A-13.8%£16.33M£15.64M-10.3680Gap Down Related Companies and Tools Related Companies Feedback Alternatives Trellus Health Alternatives DeepVerge Alternatives Sensyne Health Alternatives EMIS Group Alternatives Craneware Alternatives Instem Alternatives Kooth Alternatives Renalytix Alternatives Cambridge Cognition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:IQAI) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IQ-AI Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share IQ-AI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
